logo
Plus   Neg
Share
Email

DOW In Deal With France's DEINOVE To Develop New Cosmetic Active Ingredient

French biotechnology company DEINOVE announced a collaboration with Dow Inc. (DOW) for the joint development of a cosmetic ingredient derived from its collection of bacterial extracts. Under the deal, Dow has selected an extract belonging to the DEINOVE proprietary strains' bank to unveils a new cosmetic active ingredient for skin care applications.

The commercialization is planned for early 2021.

DEINOVE owns a large bacterial collection that currently includes more than 6,000 rare strains, collected in many different biotopes and on various substrates. The company has developed original and patented methods for the selection and culture of these rare bacteria.

DEINOVE will now develop and optimize a dedicated production process and will ensure the industrial transposition and production of the developed cosmetic active. The cosmetic active will be integrated into Dow's product portfolio, receiving commercial exclusivity worldwide.

Fabienne Bizeray, Dow's Global Strategic Marketing Leader Skin & Sun Care, said, "After the launch of AgeCap Smooth in April 2018, this agreement will allow Dow to quickly develop a new natural cosmetic ingredient for our customers. This first collaboration with DEINOVE is perfectly aligned with our strategy of expanding and transforming our portfolio dedicated to skin care."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Apple Inc. (AAPL) unveiled a 16-inch MacBook Pro laptop with a larger screen and redesigned keyboard. It is the first major update since the MacBook Pro line was revamped three years ago. The company has moved from a 15-inch screen to a higher-resolution 16-inch screen. Facebook has launched its new payment platform called 'Facebook Pay' in the U.S., joining other tech giants like Google and Apple that have their own payment platforms. The new service will be available across Facebook and its associated apps - Messenger, Instagram and WhatsApp, the social media giant said in a blog post. The payment service supports most major credit and debit cards. Amneal Pharmaceuticals, LLC recalled certain lots of heartburn medication Ranitidine in the form of tablets and syrup for the potential presence of nitrosamine impurity, N-Nitrosodimethylamine, above levels established by the U.S. Food and Drug Administration or FDA. The generic and specialty pharma company is recalling 94 lots of Ranitidine tablets and Syrup.
Follow RTT
>